1. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial. Issue 3 (March 2022) Authors: Goldstone, Stephen E; Giuliano, Anna R; Palefsky, Joel M; Lazcano-Ponce, Eduardo; Penny, Mary E; Cabello, Robinson E; Moreira, Edson D; Baraldi, Ezio; Jessen, Heiko; Ferenczy, Alex; Kurman, Robert; Ronnett, Brigitte M; Stoler, Mark H; Bautista, Oliver; Das, Rituparna; Group, Thomas; Luxembourg, A... Journal: Lancet infectious diseases Issue: Volume 22:Issue 3(2022) Page Start: 413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗